| Literature DB >> 33358020 |
Suzanne M Pilkington1, Silvia Bulfone-Paus2, Christopher E M Griffiths3, Rachel E B Watson3.
Abstract
As global life expectancy continues to rise, we are challenged with maintaining health into old age. One strategy is to target the chronic low-level inflammation associated with aging, termed inflammaging. This is characterized by increased levels of circulating proinflammatory cytokines and a shift toward cellular senescence, changes that are believed to drive many age-associated conditions, including dementia, arthritis, and type 2 diabetes. As with other organs, the skin undergoes functional decline during aging, becoming more fragile and susceptible to infection; however, the contribution of inflammaging is not well-understood. This review article describes the evidence for inflammaging in the skin, its relationship with senescence, and how this relates to declining skin structure and function.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33358020 DOI: 10.1016/j.jid.2020.11.006
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551